CD274 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: The multi-institutional report of 43 patients with nccRCC treated with PD-1/PD-L1 therapy including three patients with tRCC was notable for one patient with a PR, one patient with SD, and one patient with PD [42].